神经重症监护病房中肌无力患者院内死亡病因分析
该研究回顾性分析中国两家大型综合医院神经重症单元2014年1月至2023年12月共10年的肌无力患者数据。3723例患者中院内死亡79例(2.12%),其中胸腺瘤患者52例(65.82%)。与非胸腺瘤性肌无力组(n=27)相比,胸腺瘤性肌无力组(n=52)死亡年龄更轻(53.71±14.01岁 vs 65.37±14.61岁,p=0.001)。脓毒性休克是最常见根本死因(32例,40.51%),其次为肌无力危象(18例,22.78%),该趋势在两组中均存在。胸腺瘤组中暴发性心肌炎为第三位根本死因(9例,17.31%),而非胸腺瘤组无暴发性心肌炎病例。所有死亡患者中肺炎是最常见感染(55例,69.62%)。
要点
- 3723例肌无力患者中院内死亡79例(2.12%),胸腺瘤患者占死亡病例的65.82%(52例)。
- 脓毒性休克是最常见根本死因(32例,40.51%),其次为肌无力危象(18例,22.78%),胸腺瘤与非胸腺瘤组趋势一致。
- 胸腺瘤性肌无力患者死亡年龄显著低于非胸腺瘤组(53.71±14.01岁 vs 65.37±14.61岁,p=0.001)。
- 胸腺瘤组暴发性心肌炎为第三位根本死因(9例,17.31%),非胸腺瘤组无暴发性心肌炎病例。
- 所有死亡患者中肺炎最常见(55例,69.62%),其次为尿路感染(14例,17.72%)、血流感染(13例,16.46%)、颅内感染(7例,8.86%)。
适用人群与场景
- 中国两家大型综合医院神经重症单元收治的肌无力患者,时间跨度2014年1月至2023年12月。
- 死亡病例分析纳入79例院内死亡患者,其中胸腺瘤性肌无力52例,非胸腺瘤性肌无力27例。
研究设计与关键结果
- 研究类型为回顾性分析,样本量3723例,来自中国两家大型综合医院神经重症单元,时间2014年1月至2023年12月。
- 总体院内死亡率为2.12%(79/3723),死亡患者中胸腺瘤占65.82%(52例)。
- 胸腺瘤性肌无力组(n=52)死亡年龄53.71±14.01岁,非胸腺瘤性肌无力组(n=27)为65.37±14.61岁,胸腺瘤组死亡年龄更轻(p=0.001)。
- 脓毒性休克为最常见根本死因(32例,40.51%),肌无力危象次之(18例,22.78%),该趋势在胸腺瘤组和非胸腺瘤组均存在。
- 胸腺瘤组暴发性心肌炎为第三位根本死因(9例,17.31%),非胸腺瘤组无暴发性心肌炎病例。
- 所有死亡患者中,肺炎最常见(55例,69.62%),其次为尿路感染(14例,17.72%)、血流感染(13例,16.46%)、颅内感染(7例,8.86%)。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为胸腺瘤可能增加死亡风险,脓毒性休克和肌无力危象是肌无力患者最常见的根本死因。
- 在神经重症单元中,对肌无力患者应关注脓毒性休克和肌无力危象的防治,尤其胸腺瘤患者死亡年龄更轻且需警惕暴发性心肌炎。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Our objective was to investigate the characteristics and causes of death in deceased patients with myasthenia gravis (MG).
METHODS: This study conducted a retrospective analysis of data from patients with MG in the neurocritical unit at two large general hospitals in China spanning 10 years, from January 2014 to December 2023. Detailed demographic and clinical information were collected for deceased patients. Experienced physicians determined both the underlying and direct causes of death.
RESULTS: Among 3723 patients, the overall hospitalized mortality was 79 (2.12%). Thymoma was present in 52 (65.82%) of these patients. Compared with the nonthymomatous MG (NTMG) group (n = 27), patients with thymomatous MG (TMG) (n = 52) were significantly younger at death (53.71 ± 14.01 years vs. 65.37 ± 14.61 years, p = 0.001). Septic shock was the most common underlying cause of death, affecting 32 (40.51%) patients, followed by myasthenic crisis in 18 (22.78%) patients. This trend was observed in both the TMG and NTMG groups. In the TMG group, fulminant myocarditis was the third leading underlying cause of death in 9 (17.31%) patients, whereas no cases of fulminant myocarditis were reported in the NTMG group. Among all deceased patients (n = 79), pneumonia was the most common infection, affecting 55 (69.62%) patients, followed by urinary tract infections in 14 (17.72%) patients, bloodstream infections in 13 (16.46%) patients, and intracranial infections in 7 (8.86%) patients.
CONCLUSIONS: The study suggests that thymoma may increase the risk of death, with septic shock and myasthenic crisis being the most frequent underlying causes in patients with MG.
参考来源
- Chen H, Wang Y, Zhang N, et al. The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit. Neurocrit Care. 2025. PMID: 40877497. doi:10.1007/s12028-025-02352-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。